arbutus-biopharma
Delivered
Earnings Eye detected this earnings release on Friday, March 21, 2025 at 2:30:19 AM EDT and has distributed notifications to the Telegram channels listed at the bottom of the page.
Data sources leveraged on this page come from:
Company Information
- Ticker Symbol
- ABUS
- Stock Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
Stock Trading Snapshot
- Market Cap
- $627.2M
- Current Price
- $3.3100
- Previous Close
- $3.3100
- Price Change
- 0.0000%
- Average Volume
- 833.3K
- Volume Amount
- $839.9K
Financial Metrics
Earnings Per Share
- Estimate
- $-0.075000
- Actual
- $-0.075000
- Surprise
- $0.000000
- Surprise %
- 0.0000%
Revenue
- Estimate
- $1.7M
- Actual
- $1.6M
- Surprise
- $-80.5K
- Surprise %
- -4.8788%
Notification Distribution
List of notifications sent to Telegram channels
Earnings releasedSent
3/21/25, 2:30 AM
ABUS EPS Surprise:N/A Revenue Surprise: -4.88% EPS chain: $-19.80M / $-19.72M / $-0.08(Est: $-0.07) Revenue chain: $1.73M / $1.34M / $1.57M($1.30M) MA50/MA200: 3.33 / 3.59 52WeekRange: 2.30~4.72 Close Price: 3.3100 Current Price: 3.3100 / +0.00%% Market Cap: $627.22M Sector: Healthcare - Biotechnology Release_date: 2025-03-21 06:30:19.318313+00:00 More details >>
Terminology
Term | Definition |
---|---|
Ticker Symbol | A unique series of letters representing a publicly traded security. |
Stock Exchange | The marketplace where securities are traded. |
Sector | A category of the economy in which the company operates. |
Industry | A specific category within a sector. |
Market Cap | The total market value of a company's outstanding shares. |
Current Price | The latest trading price of the stock. |
Previous Close | The stock's closing price on the previous trading day. |
Price Change | The percentage change in the stock's price from the previous close. |
Average Volume | The average number of shares traded over a specific period. |
Volume Amount | The total monetary value of shares traded. |
Earnings Per Share | The portion of a company's profit allocated to each outstanding share. |
Revenue | The total income generated by the company. |
Estimate | The predicted value by analysts. |
Actual | The reported value by the company. |
Surprise | The difference between actual and estimated values. |
Surprise % | The percentage difference between actual and estimated values. |